Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Clavel, François"'
Autor:
Vray M; INSERM EMI 0214, Université Pierre et Marie Curie, Paris, France. murielvray@hotmail.com, Meynard JL, Dalban C, Morand-Joubert L, Clavel F, Brun-Vézinet F, Peytavin G, Costagliola D, Girard PM
Publikováno v:
Antiviral therapy [Antivir Ther] 2003 Oct; Vol. 8 (5), pp. 427-34.
Autor:
Duval X; Service des Maladies Infectieuses et Tropicales, Hôpital Bichat Claude Bernard, Paris, France. xavier.duval@bch.ap-hop-paris.fr, Lamotte C, Race E, Descamps D, Damond F, Clavel F, Leport C, Peytavin G, Vilde JL
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2002 Feb; Vol. 46 (2), pp. 570-4.
Autor:
Andréoletti L, Weiss L, Si-Mohamed A, Piketty C, Prazuck T, Calamy G, Malkin JE, Matta M, Mbopi-Kéou FX, Clavel F, Kazatchkine MD, Bélec L
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2002 Jan 01; Vol. 29 (1), pp. 102-4.
Autor:
Barrail-Tran, Aurélie, Morand-Joubert, Laurence, Poizat, Gwendoline, Raguin, Gilles, Le Tiec, Clotilde, Clavel, François, Dam, Elisabeth, Chêne, Geneviève, Girard, Pierre-Marie, Taburet, Anne-Marie, Study Group, Puzzle-1
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2008, 52 (5), pp.1642-6. ⟨10.1128/AAC.01314-07⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2008, 52 (5), pp.1642-6. ⟨10.1128/AAC.01314-07⟩
The inhibitory quotient (IQ) of human immunodeficiency virus (HIV) protease inhibitors (PIs), which is the ratio of drug concentration to viral susceptibility, is considered to be predictive of the virological response. We used several approaches to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec13390052587c59dba4c7e78a6ea90c
https://www.hal.inserm.fr/inserm-00263587/document
https://www.hal.inserm.fr/inserm-00263587/document